Viewing Study NCT02727803


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-02-25 @ 5:23 PM
Study NCT ID: NCT02727803
Status: RECRUITING
Last Update Posted: 2025-11-06
First Post: 2016-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized NK Cell Therapy in CBT
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Acute Biphenotypic Leukemia View
None Acute Lymphoblastic Leukemia View
None Acute Lymphoblastic Leukemia in Remission View
None Acute Myeloid Leukemia With Myelodysplasia-Related Changes View
None Acute Myeloid Leukemia With Variant MLL Translocations View
None B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 View
None Chemotherapy-Related Leukemia View
None Chronic Myelomonocytic Leukemia View
None Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 … View
None ISS Stage II Plasma Cell Myeloma View
None ISS Stage III Plasma Cell Myeloma View
None Myelodysplastic Syndrome View
None Myelodysplastic Syndrome With Excess Blasts View
None Myelodysplastic Syndrome With Gene Mutation View
None Myelodysplastic/Myeloproliferative Neoplasm View
None Previously Treated Myelodysplastic Syndrome View
None Recurrent Acute Myeloid Leukemia View
None Recurrent Adult Acute Myeloid Leukemia View
None Recurrent Hodgkin Lymphoma View
None Recurrent Non-Hodgkin Lymphoma View
None Refractory Acute Lymphoblastic Leukemia View
None Refractory Adult Acute Lymphoblastic Leukemia View
None Secondary Acute Myeloid Leukemia View
None Therapy-Related Myelodysplastic Syndrome View
Keywords: